Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease

Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease

Masakazu Ichinose,1 Ayako Takizawa,2 Toshiyasu Izumoto,2 Yusuke Tadayasu,2 Alan L Hamilton,3 Christina Kunz,4 Yoshinosuke Fukuchi51Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan; 2Nippon Boehringer Ingelheim Co. Ltd, Tokyo, Japan; 3Boehringer Ingelhe...

Full description

Bibliographic Details
Main Authors: Ichinose M, Takizawa A, Izumoto T, Tadayasu Y, Hamilton AL, Kunz C, Fukuchi Y
Format: Article
Language:English
Published: Dove Medical Press 2015-08-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/efficacy-and-safety-of-the-long-acting-beta2-agonist-olodaterol-over-4-peer-reviewed-article-COPD

Internet

http://www.dovepress.com/efficacy-and-safety-of-the-long-acting-beta2-agonist-olodaterol-over-4-peer-reviewed-article-COPD

Similar Items